Your browser doesn't support javascript.
loading
First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors.
Yap, Timothy A; Tan, David S P; Terbuch, Angelika; Caldwell, Reece; Guo, Christina; Goh, Boon Cher; Heong, Valerie; Haris, Noor R Md; Bashir, Saira; Drew, Yvette; Hong, David S; Meric-Bernstam, Funda; Wilkinson, Gary; Hreiki, Joseph; Wengner, Antje M; Bladt, Friedhelm; Schlicker, Andreas; Ludwig, Matthias; Zhou, Yinghui; Liu, Li; Bordia, Sonal; Plummer, Ruth; Lagkadinou, Eleni; de Bono, Johann S.
Afiliação
  • Yap TA; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tan DSP; National University Cancer Institute and National University Hospital and Cancer Science Institute, National University of Singapore, Singapore.
  • Terbuch A; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom.
  • Caldwell R; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Guo C; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom.
  • Goh BC; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom.
  • Heong V; National University Cancer Institute and National University Hospital and Cancer Science Institute, National University of Singapore, Singapore.
  • Haris NRM; National University Cancer Institute and National University Hospital and Cancer Science Institute, National University of Singapore, Singapore.
  • Bashir S; Translational and Clinical Research Institute, Newcastle University and Northern Centre for Cancer Care, Newcastle, United Kingdom.
  • Drew Y; Translational and Clinical Research Institute, Newcastle University and Northern Centre for Cancer Care, Newcastle, United Kingdom.
  • Hong DS; Translational and Clinical Research Institute, Newcastle University and Northern Centre for Cancer Care, Newcastle, United Kingdom.
  • Meric-Bernstam F; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wilkinson G; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hreiki J; Bayer AG, Berlin, Germany.
  • Wengner AM; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey.
  • Bladt F; Bayer AG, Berlin, Germany.
  • Schlicker A; Bayer AG, Berlin, Germany.
  • Ludwig M; Bayer AG, Berlin, Germany.
  • Zhou Y; Bayer AG, Berlin, Germany.
  • Liu L; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey.
  • Bordia S; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey.
  • Plummer R; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey.
  • Lagkadinou E; Translational and Clinical Research Institute, Newcastle University and Northern Centre for Cancer Care, Newcastle, United Kingdom.
  • de Bono JS; Bayer AG, Berlin, Germany.
Cancer Discov ; 11(1): 80-91, 2021 01.
Article em En | MEDLINE | ID: mdl-32988960
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ataxia Telangiectasia / Neoplasias Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ataxia Telangiectasia / Neoplasias Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos